Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China

Published:2013-12-10 Issue:12 Volume:8 Page:e83396
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tan Chongqing,Peng Liubao,Zeng Xiaohui,Li Jianhe,Wan Xiaomin,Chen Gannong,Yi Lidan,Luo Xia,Zhao Ziying

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Stomach Cancer Incidence, Mortality and Prevalence Worldwide in 2008 Summary,2008

2. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis;Group;JAMA,2010

3. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine;S Sakuramoto;N Engl J Med,2007

4. NCCN clinical practice guidelines in Oncology-Gastric cancer guideline;Chinese,2010

5. NCCN clinical practice guidelines in Oncology-Gastric cancer guideline;Chinese,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma;BMJ Open;2022-11

2. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English;Applied Health Economics and Health Policy;2021-07-29

3. A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China;Cancer Medicine;2020-10-13

4. Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China;PLOS ONE;2020-05-07

5. Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis;Frontiers in Oncology;2019-12-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3